Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College Students

Обзор

Approximately 60% of males and 40% of females do not meet current fluid intake recommendations, which is associated with adverse health consequences such as obesity, diabetes, and chronic kidney disease. Newer technologies have been designed to promote fluid intake. "Smart Water Bottles" use mHealth technology to capture fluid intake behaviors automatically and provide cues to encourage fluid consumption. Studies using Smart Water Bottles have helped some individuals increase fluid intake to help reduce kidney stone formation. However, limited research has assessed the efficacy of this technology on improving fluid intake in college students. College is a time with the potential to form healthy habits that carry into adulthood. Previous work has also identified daily changes in morning urine color, thirst perception, and body mass, as simple, inexpensive indicators of daily fluctuations in water balance. Tracking changes in these metrics has the potential to provide participants with evidence of adequate or inadequate fluid consumption. Thus, the combination of prompting from a smart water bottle, as well as daily self-monitoring changes in hydration status, may encourage college students to increase daily fluid consumption.

Вмешательства

• Поведенческое Smart Water Bottle
  Participants in the intervention group will receive a bottle which measures participant fluid consumption. The bottle will be set to recommend 2.5L for male participants and 2.0L for female participants, consistent with fluid intake recommendations from the European Food Safety Authority for each sex. Participants will be prompted by the bottle (bottle will light up) when they are behind on fluid intake recommendations. Participants will use a validated urine color chart, 9 point Likert scale fo

Первичные конечные точки

• Total Fluid Intake [Срок оценки: Pre and Post 2-week intervention]
• Changes in 24h urine osmolality [Срок оценки: Pre and Post 2-week intervention]
• Changes in 24h urine volume [Срок оценки: Pre and Post 2-week intervention]

Вторичные конечные точки (8)

• Change in urine color measured by validated urine color chart [Срок оценки: Pre and Post 2-week intervention]
• Changes in calorie intake from dietary log. [Срок оценки: Pre and Post 2-week intervention]
• Change in copeptin [Срок оценки: Pre and Post 2-week intervention]
• Change in urine specific gravity [Срок оценки: Pre and Post 2-week intervention]
• Change in body water distribution [Срок оценки: Pre and Post 2-week intervention]
• Change in Aldosterone [Срок оценки: Pre and Post 2-week intervention]
• Hydration KAB Scales [Срок оценки: Pre and Post 2-week intervention.]
• Change in body fat percentage [Срок оценки: Pre and Post 2-week intervention]

Критерии участия

Критерии включения

• Participants must report currently drinking less than the European Food Safety Authority Recommendations for fluid, as determined by an online pre-screening survey (<2.5 L per day for males; <2.0 L per day for females).
• Has access to a cell phone which can download the app associated with the Smart Water Bottle.

Критерии исключения

• Currently trying to gain or lose weight
• Have had surgery of the digestive tract
• Currently taking diuretics (e.g., Thiazide, Loop diuretics or potassium-sparing diuretics)
• Currently taking centrally-acting medications (e.g., anesthetics, anticonvulsants, central nervous system stimulants/amphetamines, muscle relaxants)
• Report currently consuming at least the European Food Safety Authority Recommendations for fluid, as determined by an online pre-screening survey (>= 2.5 L per day for males, >=2.0 L per day for females).
• Currently pregnant (females)

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Простое слепое

Основная цель

Профилактика

Центры проведения

США · 1 центр

• Kennesaw State University — Kennesaw

Идентификаторы

NCT: NCT06259799 · MZ

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗